查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1304586

全球阴道镜市场 - 2023-2030

Global Colposcopes Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概述

全球阴道镜市场规模在2022年达到6亿美元，预计到2030年将实现9亿美元的强劲增长。在预测期内（2023-2030年），全球阴道镜市场预计将呈现5.7%的复合年增长率。技术的不断进步和对新型产品投资的不断增长推动了阴道镜市场需求的发展趋势。

阴道镜市场包括确定是否存在宫颈癌或外阴癌等其他疾病的检测。技术先进的新产品的推出以及宫颈癌患者的增加是推动全球阴道镜市场发展的主要因素。

阴道镜的市场范围包括宫颈癌筛查、体格检查及其他应用，这增加了阴道镜的市场份额。全球阴道镜市场正在不断扩大，其原因包括不断增加的研究和开发，以及各国即将批准的新型产品，这也为阴道镜市场的增长创造了积极的前景。

市场动态

越来越多的女性采用阴道镜进行细胞学管理，推动了癌症诊断市场的增长。

通过细胞学检查可确定哪些妇女更有可能罹患浸润性癌症或高级别宫颈癌前病变。对于细胞学异常的妇女，阴道镜等诊断性检查对于定位异常、确诊和确定最佳治疗方案至关重要。

"即看即治 "策略为阴道镜怀疑有高级别病变的妇女提供治疗，而无需等待组织学确诊。事实证明，这一策略可降低随访损失率，并有效利用偏远地区有限的医疗资源。

在一项基于印度社区的研究中，训练有素的护士对VIA阳性的妇女进行阴道镜检查，如果发现异常病变，当天就为妇女提供冷冻治疗（前提是病变符合消融治疗的要求）。CIN1（宫颈上皮内瘤变）妇女的治愈率为81.4%；CIN2为71.4%；CIN3为68.0%。近75%符合条件的妇女在同一次就诊时接受了治疗。

主要公司的研发和新产品发布为制造商创造了有利的机会

由人工智能（AI）驱动的数字移动阴道镜为目前的宫颈癌标准治疗提供了一种筛查选择，有望大大提高准确性和速度 - 提供结果的时间不到一分钟。MobileODT公司（以色列特拉维夫）的EVAPro引进了宫颈癌筛查的最新技术发展，增强了患者与医生之间的互动。

最新的EVAPro数字阴道镜轻巧便携，具有出色的图像质量和尖端的软件功能。医生可以利用这一特殊组合记录、跟踪和存储整个治疗过程。EVAPro图像的自发光特性使图像捕捉更加清晰。绿色滤光片用于图像分析，以评估异常动脉和其他地标或病变。在使用自动对焦时，每张图像都会对宫颈的存在、照明、位置和焦点进行评估。

图像质量可通过图像引导技术和机器学习（ML）进行评估，告知医生图像是否适合目测检查或阴道镜检查。EVAPro使用机器学习（ML）和人工智能（AI）进行广泛的宫颈癌筛查。在护理点，VisualCheck是基于人工智能的计算机辅助诊断工具，可使用EVAPro数字阴道镜评估发育不良的风险。

结肠镜的替代品将阻碍市场增长。

全球对阴道镜的需求正受到结肠镜替代品可用性等问题的制约。在早期研究中，宫颈数码摄影（CDP）曾被提议作为宫颈筛查的替代技术。

CDP是一种很有前途的阴道镜替代技术。随着进一步的研究，CDP在临床实践中的总体效用可能会得到更好的理解。阴道镜检查或宫颈摄影的在线表格也可能有用。此外，使用智能手机摄像头也可替代阴道镜检查。

COVID-19 影响分析

COVID-19疫情爆发和全球封锁影响了各行业公司的财务稳定性。因此，美国食品和药物管理局(FDA)发布了COVID-19卫生紧急状态期间的指导方针，其中包括协助申办者和研究人员、确保试验参与者安全、遵循良好临床实践(GCP)和降低试验完整性风险的一般注意事项。

俄乌战争影响分析

据估计，俄乌冲突对全球阴道镜市场的影响较小，因为该地区的主要市场参与者较少。然而，原材料进出口的影响预计在预测期内对全球阴道镜市场增长的影响不大。

目录

第一章 研究方法和范围

  • 研究方法
  • 研究目的和报告范围

第2章：定义和概述

第3章：执行摘要

  • 按类型摘录
  • 按产品类型划分
  • 按便携性划分
  • 按应用分类
  • 按最终用户分类
  • 按地区划分

第四章 动态

  • 影响因素
    • 驱动因素
      • 阴道镜在妇女细胞学管理中的应用不断增加
      • 宫颈癌发病率上升
    • 限制因素
      • 阴道镜替代品的出现
    • 机会
      • 研发和新产品的不断推出
    • 影响分析

第五章 : 行业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 法规分析

第6章：COVID-19分析

  • COVID-19分析
    • COVID-19之前的情况
    • COVID-19期间的情景
    • COVID-19之后的情况
  • COVID-19期间的定价动态
  • 供求关系
  • 大流行期间与市场相关的政府倡议
  • 制造商的战略倡议
  • 结论

第七章：按产品分类

  • 光学阴道镜
  • 数字阴道镜

第八章：按产品类型

  • 视频
  • 双目

第九章：按便携性

  • 手推车式
  • 手持式

第十章：按应用

  • 宫颈癌筛查
  • 体格检查
  • 其他应用

第十一章：按最终用户分类

  • 医院
  • 诊断实验室
  • 专科诊所
  • 其他

第十二章：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美其他地区
  • 亚太地区
    • 中国
    • 日本
    • 日本
      • 亚太其它地区
  • 中东和非洲
    • 主要地区动态

第十三章 ：竞争格局

  • 竞争格局
  • 市场定位/份额分析
  • 合併与收购分析

第十四章：公司简介

  • Olympus Corporation
    • 公司概况
    • 产品组合和描述
    • 财务概况
    • 主要发展
  • CooperSurgical Inc.
  • McKesson Medical-Surgical Inc.
  • DYSIS Medical Inc.
  • Gynex Corporation
  • Ecleris
  • Karl Kaps GmbH & Co. KG
  • Medgyn Products Inc.
  • Delmont imaging
  • Seiler Instrument Inc.

第15章 ：附录

简介目录
Product Code: MD2384

Market Overview

The global colposcopes market reached US$ 0.6 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 0.9 billion by 2030. The global colposcopes market is expected to exhibit a CAGR of 5.7% during the forecast period (2023-2030). The increasing technological advancements and the growing investments for novel products are driving up demand for colposcopes market trends.

The market for colposcopes includes tests that establish the existence of the cervical cancer or other diseases such as vulvar cancer and more. The launch of new technologically advanced products, and an increase in patients with cervical cancer are the main factors propelling the global market for colposcopes.

The colposcopes market scope comprises application as cervical cancer screening, physical examinations and others, which has increased the colposcopes market share. The global market for colposcopes is expanding as a result of factors including the increasing research and development and their upcoming novel product approvals across countries are also creating a positive outlook for the colposcopes market growth.

Market Dynamics

Increasing Adoption of Colposcopes for Women Cytology Management Drive the Growth of the Cancer Diagnostic market

Women who are more likely to have invasive cancer or high-grade cervical premalignant lesions are identified by cytology. For women with abnormal cytology, a diagnostic test such a colposcopy is essential for localizing the abnormality, confirming the diagnosis, and determining the best course of treatment.

The "see and treat" strategy offers treatment to women who have high-grade lesions that are colposcopically suspected without waiting for histology confirmation. This strategy has been demonstrated to reduce the rates of follow-up loss and to effectively use the limited medical resources available in remote places.

In an Indian community-based study, trained nurses performed colposcopies on VIA-positive women, and if abnormal lesions were found, the women were offered cryotherapy treatment the same day (provided the lesion met the requirements for treatment by ablation). The cure results were 81.4% for women having CIN 1 (Cervical Intra-epithelial Neoplasia); 71.4% for CIN 2; and 68.0% for CIN 3. Almost 75 percent of eligible women accepted therapy at the same visit.

Rising Research and Development and Novel Product Launch by Key Companies creates Lucrative Opportunities for Manufacturers

A digital mobile colposcope powered by artificial intelligence (AI) offers a screening option to the current standard treatment for cervical cancer, promising greatly improved accuracy and speed-delivery of results takes less than a minute. The EVAPro from MobileODT (Tel Aviv, Israel) introduces the most recent technological development in cervical cancer screening, enhancing the patient-physician interaction.

The latest EVAPro digital colposcope is portable and light, with outstanding image quality and cutting-edge software capabilities. Doctors can record, track, and store the full course of treatment using this special combination. The self-illuminating nature of EVAPro pictures makes for crisper image capturing. A green filter is used in image analysis to assess aberrant arteries and other landmarks or lesions. The existence, illumination, location, and focus of the cervix are all evaluated for each image while using autofocus.

Image quality can be assessed using image-guided technology and machine learning (ML), informing the doctor if the image would be appropriate for visual examination or colposcopic review. EVAPro uses machine learning (ML) and artificial intelligence (AI) for extensive cervical cancer screening. At the point of care, VisualCheck, based on artificial intelligence, computer-aided diagnostic tool, assesses the risk of dysplasia using the EVAPro digital colposcope.

Availability of Alternatives for Colonoscopes will Hamper the Growth of the Market.

Global demand for colposcopes is being restrained by issues like the availability of alternatives for colonoscopes. In earlier investigations, cervical digital photography (CDP) was previously proposed as an alternate cervical screening technique.

A promising substitute for colposcopy is CDP. The overall usefulness of CDP in clinical practice may be better understood with further study. Online forms for colposcopy or cervical photography may also be useful. Additionally, using a smartphone camera could be a useful substitute for colposcopy.

COVID-19 Impact Analysis

The financial stability of companies across all industries has been impacted by the COVID-19 outbreak and the global lockdown. As a result, the U.S. Food and Drug Administration (FDA) released guidelines for the duration of the COVID-19 health emergency that include general considerations to assist sponsors and researchers, ensure trial participants' safety, follow good clinical practice (GCP), and reduce risks to trial integrity.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a low impact on the global colposcopes market, owing to the low number of key market players in this region. However, the impact of the import and export of raw materials is expected to have little influence over the global colposcopes market growth over the forecast period.

Segment Analysis

The global colposcopes market is segmented based on type, product type, technology, application, end user and region.

Cervical Cancer Screening from Application Segment Accounts for 56.4% of Market Share Owing to High Advantages

One kind of cervical cancer test is a colposcopy. It is a test to examine the cervix more closely. The cervix is the vaginal opening into the womb. If a cervical screening reveals cell alterations brought on by specific forms of human papillomavirus (HPV), a colposcopy is frequently performed.

The procedure of screening allows for the early diagnosis of diseases. For those who have a cervix, screening for cervical cancer is an essential component of regular medical care. Finding precancerous alterations in cervical cells, which can be treated to stop cervical cancer from growing, is the aim of screening for the disease. During cervical screenings, cancer can occasionally be discovered. Usually, it is simpler to treat cervical cancer in its early stages.

Cervical cancer cells may develop from these altered cells. Colposcopy is still the preferred procedure in high-resource settings following a positive cervical cytology or human papillomavirus (HPV) test result. The quantity and location of biopsies, as well as the training and experience of the colposcopists, all have a significant impact on how well colposcopy can guide treatment.

Geographical Analysis

North America Accounted for Approximately 39.5% of the Market Share Owing to the Strong Presence of Major Players and the Advancements in Cancer Diagnostics

Manufacturers have chances to expand their operations in this region because of the rising demand for colposcopes for advancements in North America. The area has many producers and suppliers, and its rapid economic development has raised industrial production of colposcopes, which has increased the demand.

There are many manufacturers and suppliers in North America, and as a result of the region's rapid economic growth, industrial production has expanded, feeding the desire for research and development of novel products.

As new technologies for research and development are developed, the market will expand. Rising technological developments, governmental approvals, and the introduction of new products all contribute to growth. People are becoming more aware of novel products and technologies, leading to the expansion of the market in this region. These factors are responsible for dominance of North America.

Competitive Landscape

The major global players in the colposcopes market include: Olympus Corporation, CooperSurgical Inc., McKesson Medical-Surgical Inc., DYSIS Medical Inc., Gynex Corporation, Ecleris, Karl Kaps GmbH & Co. KG, Medgyn Products Inc., Delmont imaging and Seiler Instrument Inc. among others.

Why Purchase the Report?

  • To visualize the global colposcopes market segmentation based on type, product type, portability, application, end user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of colposcopes market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global colposcopes market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Product Type
  • 3.3. Snippet by Portability
  • 3.4. Snippet by Application
  • 3.5. Snippet by End User
  • 3.6. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Adoption of Colposcopes for Women Cytology Management
      • 4.1.1.2. Rising Incidence of Cervical Cancer
    • 4.1.2. Restraints
      • 4.1.2.1. Availability of Alternatives for Colposcopes
    • 4.1.3. Opportunity
      • 4.1.3.1. Rising Research and Development and Novel Product Launch
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Optical Colposcope *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Digital Colposcope

8. By Product Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.1.2. Market Attractiveness Index, By Product Type
  • 8.2. Video *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Binocular

9. By Portability

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 9.1.2. Market Attractiveness Index, By Portability
  • 9.2. Trolley-mounted *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Handheld

10. By Application

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.1.2. Market Attractiveness Index, By Application
  • 10.2. Cervical Cancer Screening *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Physical Examinations
  • 10.4. Others

11. By End User

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.1.2. Market Attractiveness Index, By End User
  • 11.2. Hospitals *
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. Diagnostic Laboratories
  • 11.4. Specialty Clinics
  • 11.5. Others

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.2.8.1. U.S.
      • 12.2.8.2. Canada
      • 12.2.8.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.3.8.1. Germany
      • 12.3.8.2. U.K.
      • 12.3.8.3. France
      • 12.3.8.4. Spain
      • 12.3.8.5. Italy
      • 12.3.8.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.4.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.4.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.4.6.1. Brazil
      • 12.4.6.2. Argentina
      • 12.4.6.3. Rest of South America
  • 12.5. Asia-Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1. China
      • 12.5.8.2. India
      • 12.5.8.3. Japan

Australia

      • 12.5.8.4. Rest of Asia-Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Portability
    • 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

13. Competitive Landscape

  • 13.1. Competitive Scenario
  • 13.2. Market Positioning/Share Analysis
  • 13.3. Mergers and Acquisitions Analysis

14. Company Profiles

  • 14.1. Olympus Corporation *
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Financial Overview
    • 14.1.4. Key Developments
  • 14.2. CooperSurgical Inc.
  • 14.3. McKesson Medical-Surgical Inc.
  • 14.4. DYSIS Medical Inc.
  • 14.5. Gynex Corporation
  • 14.6. Ecleris
  • 14.7. Karl Kaps GmbH & Co. KG
  • 14.8. Medgyn Products Inc.
  • 14.9. Delmont imaging
  • 14.10. Seiler Instrument Inc.

LIST NOT EXHAUSTIVE

15. Appendix

  • 15.1. About Us and Services
  • 15.2. Contact Us